ShockWave Medical, Inc. SWAV NASDAQ

ShockWave Medical, Inc. (SWAV) has shown exceptional revenue growth over the past 3 years, expanding from $68M to $730M (average +135.1%/yr). Net income reached $147M, reflecting exceptional earnings expansion at +839.5%/yr on average. The net profit margin is 20.2%, which is high. the company was profitable in 2 out of the last 4 years tracked. The gross margin is 86.9% (high), with a +17.9pp trend over the period. With a $13B market cap and MOAT composite score of 76/100, the company has a strong competitive position.

Criteria proven by this page:

• GROWTH (100/100, Pass) — proving strong growth momentum
• PAST (50/100, Fail) — the company has frequently reported losses. Looking at the full 7-year history, the company was profitable in 2 of 7 years — a mixed long-term record
• INCOME (85/100, Pass) — proves strong profitability and pricing power
• MOAT (76/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 60/100 with 4/7 criteria passed.